Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Functional Differences between IgM and IgD Signaling in Chronic Lymphocytic Leukemia.

Ten Hacken E, Sivina M, Kim E, O'Brien S, Wierda WG, Ferrajoli A, Estrov Z, Keating MJ, Oellerich T, Scielzo C, Ghia P, Caligaris-Cappio F, Burger JA.

J Immunol. 2016 Sep 15;197(6):2522-31. doi: 10.4049/jimmunol.1600915.

PMID:
27534555
2.

Synthetic Lethal Screen Demonstrates That a JAK2 Inhibitor Suppresses a BCL6-dependent IL10RA/JAK2/STAT3 Pathway in High Grade B-cell Lymphoma.

Beck D, Zobel J, Barber R, Evans S, Lezina L, Allchin RL, Blades M, Elliott R, Lord CJ, Ashworth A, Porter AC, Wagner SD.

J Biol Chem. 2016 Aug 5;291(32):16686-98. doi: 10.1074/jbc.M116.736868.

PMID:
27268052
3.

Regulation of hematopoietic development by ZBTB transcription factors.

Maeda T.

Int J Hematol. 2016 Sep;104(3):310-23. doi: 10.1007/s12185-016-2035-x. Erratum in: Int J Hematol. 2016 Sep;104(3):408.

PMID:
27250345
4.

BCL6 modulation of acute lymphoblastic leukemia response to chemotherapy.

Slone WL, Moses BS, Hare I, Evans R, Piktel D, Gibson LF.

Oncotarget. 2016 Apr 26;7(17):23439-53. doi: 10.18632/oncotarget.8273.

PMID:
27015556
5.

Reactivation of IgG-switched memory B cells by BCR-intrinsic signal amplification promotes IgG antibody production.

Lutz J, Dittmann K, Bösl MR, Winkler TH, Wienands J, Engels N.

Nat Commun. 2015 Oct 13;6:8575. doi: 10.1038/ncomms9575.

PMID:
26815242
6.

A Network Model to Describe the Terminal Differentiation of B Cells.

Méndez A, Mendoza L.

PLoS Comput Biol. 2016 Jan 11;12(1):e1004696. doi: 10.1371/journal.pcbi.1004696.

PMID:
26751566
7.

Bcl6 middle domain repressor function is required for T follicular helper cell differentiation and utilizes the corepressor MTA3.

Nance JP, Bélanger S, Johnston RJ, Hu JK, Takemori T, Crotty S.

Proc Natl Acad Sci U S A. 2015 Oct 27;112(43):13324-9. doi: 10.1073/pnas.1507312112.

PMID:
26460037
8.

Overcoming rituximab drug-resistance by the genetically engineered anti-CD20-hIFN-α fusion protein: Direct cytotoxicity and synergy with chemotherapy.

Vega GG, Franco-Cea LA, Huerta-Yepez S, Mayani H, Morrison SL, Bonavida B, Vega MI.

Int J Oncol. 2015 Nov;47(5):1735-48. doi: 10.3892/ijo.2015.3170.

PMID:
26398317
9.

Suppression of human B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin involves altered regulation of B cell lymphoma-6.

Phadnis-Moghe AS, Crawford RB, Kaminski NE.

Toxicol Sci. 2015 Mar;144(1):39-50. doi: 10.1093/toxsci/kfu257.

PMID:
25543051
10.

Protein ubiquitination in lymphoid malignancies.

Yang Y, Staudt LM.

Immunol Rev. 2015 Jan;263(1):240-56. doi: 10.1111/imr.12247. Review.

PMID:
25510281
11.

Interleukin-32α downregulates the activity of the B-cell CLL/lymphoma 6 protein by inhibiting protein kinase Cε-dependent SUMO-2 modification.

Park YS, Kang JW, Lee DH, Kim MS, Bak Y, Yang Y, Lee HG, Hong J, Yoon DY.

Oncotarget. 2014 Sep 30;5(18):8765-77.

PMID:
25245533
12.

Circulating CXCR5+PD-1+ response predicts influenza vaccine antibody responses in young adults but not elderly adults.

Herati RS, Reuter MA, Dolfi DV, Mansfield KD, Aung H, Badwan OZ, Kurupati RK, Kannan S, Ertl H, Schmader KE, Betts MR, Canaday DH, Wherry EJ.

J Immunol. 2014 Oct 1;193(7):3528-37. doi: 10.4049/jimmunol.1302503.

PMID:
25172499
13.

Reciprocal occupancy of BCL6 and STAT5 on Growth Hormone target genes: contrasting transcriptional outcomes and promoter-specific roles of p300 and HDAC3.

Lin G, LaPensee CR, Qin ZS, Schwartz J.

Mol Cell Endocrinol. 2014 Sep;395(1-2):19-31. doi: 10.1016/j.mce.2014.07.020.

PMID:
25088465
14.

Dynamic expression of BCL6 in murine conventional dendritic cells during in vivo development and activation.

Zhang TT, Liu D, Calabro S, Eisenbarth SC, Cattoretti G, Haberman AM.

PLoS One. 2014 Jun 30;9(6):e101208. doi: 10.1371/journal.pone.0101208.

PMID:
24979752
15.

MZB1 is a GRP94 cochaperone that enables proper immunoglobulin heavy chain biosynthesis upon ER stress.

Rosenbaum M, Andreani V, Kapoor T, Herp S, Flach H, Duchniewicz M, Grosschedl R.

Genes Dev. 2014 Jun 1;28(11):1165-78. doi: 10.1101/gad.240762.114.

PMID:
24888588
16.

MicroRNA 28 controls cell proliferation and is down-regulated in B-cell lymphomas.

Schneider C, Setty M, Holmes AB, Maute RL, Leslie CS, Mussolin L, Rosolen A, Dalla-Favera R, Basso K.

Proc Natl Acad Sci U S A. 2014 Jun 3;111(22):8185-90. doi: 10.1073/pnas.1322466111.

PMID:
24843176
17.

Breaking bad in the germinal center: how deregulation of BCL6 contributes to lymphomagenesis.

Hatzi K, Melnick A.

Trends Mol Med. 2014 Jun;20(6):343-52. doi: 10.1016/j.molmed.2014.03.001. Review.

PMID:
24698494
18.

Diacylglycerol kinase ζ limits B cell antigen receptor-dependent activation of ERK signaling to inhibit early antibody responses.

Wheeler ML, Dong MB, Brink R, Zhong XP, DeFranco AL.

Sci Signal. 2013 Oct 15;6(297):ra91. doi: 10.1126/scisignal.2004189.

PMID:
24129701
19.

The zinc finger transcription factor ZXDC activates CCL2 gene expression by opposing BCL6-mediated repression.

Ramsey JE, Fontes JD.

Mol Immunol. 2013 Dec;56(4):768-80. doi: 10.1016/j.molimm.2013.07.001.

PMID:
23954399
20.

TLR2, TLR4 and the MyD88 signaling are crucial for the in vivo generation and the longevity of long-lived antibody-secreting cells.

Komegae EN, Grund LZ, Lopes-Ferreira M, Lima C.

PLoS One. 2013 Aug 5;8(8):e71185. doi: 10.1371/journal.pone.0071185.

PMID:
23940714
Items per page

Supplemental Content

Support Center